If you’ve tried two or three antidepressants and still don’t feel like yourself, you’re not alone, and you haven’t run out of options. What is treatment-resistant depression? It’s the term psychiatrists use when depression hasn’t improved enough despite adequate treatment, and it describes the illness, not a failure on your part. The label can sound final. In practice, it’s a signal to step back and ask better questions. Was the diagnosis right? Were earlier trials long enough, and at a high enough dose? Is something medical getting in the way? What hasn’t been tried yet? This guide explains how treatment-resistant depression is defined, why it happens, and how a psychiatrist builds the next plan with you.
What Is Treatment-Resistant Depression?

Treatment-resistant depression is major depression that hasn’t responded well enough to at least two different antidepressants, each taken at an adequate dose for an adequate length of time. That’s the most common working definition, but it isn’t universal. A review prepared for the Centers for Medicare & Medicaid Services and the Agency for Healthcare Research and Quality found no consensus definition of treatment-resistant depression; the most frequent version required two prior treatment failures with confirmed adequate dose and duration. The same review found no clear agreement on what counts as an adequate dose or an adequate duration. That matters for you, because a trial that was too short or too low doesn’t tell us much about whether the medication could have worked.
Treatment-resistant depression (TRD) is major depressive disorder that has not improved enough after at least two adequate antidepressant trials, meaning each medication was taken consistently at a therapeutic dose for long enough to judge.
The treatment-resistant depression definition psychiatrists use in practice
In the clinic, the definition turns into practical questions. How many medications have you taken for this episode of depression, not just over your lifetime? What doses did you reach, and for how long? Did you stop because the medication wasn’t helping, or because side effects were too hard to live with? Did symptoms improve partway and then plateau? The answers separate true resistance from what psychiatrists call pseudoresistance, where earlier treatment never got a fair test. Both deserve attention. They just point to different next steps.
Pseudoresistance describes depression that looks treatment-resistant but hasn’t had adequate treatment, for example because a medication was stopped early, kept at a low dose, or taken inconsistently.
Why Are My Antidepressants Not Working?
When antidepressants are not working, the reason is usually one of four things: the trial wasn’t adequate, the medication isn’t the right fit for your depression, something else is driving your symptoms, or the depression is harder to treat. One of the largest real-world studies of this question is STAR*D, an NIMH-funded trial of more than 3,600 outpatients that moved people through as many as four treatment steps. Remission rates in STAR*D were 36.8% at the first step and 30.6% at the second, then dropped to 13.7% and 13.0% at the third and fourth. The steep drop after two steps is one reason two unsuccessful trials became the common threshold for calling depression treatment-resistant.
Most first-line antidepressants are SSRIs, which act mainly on serotonin. After two SSRIs haven’t helped, many psychiatrists look at a medication with a different mechanism, such as one that also acts on norepinephrine or dopamine. The evidence here calls for humility: in STAR*D, switching within the same class and switching to a different class produced similar remission rates on average. Averages hide individual differences, though, which is why your full history matters more than any single rule.
What are the causes of treatment-resistant depression?
The causes of treatment-resistant depression usually involve more than one factor. Common contributors include a diagnosis that doesn’t fully explain the symptoms (our overview of mood disorder diagnosis covers how subtypes differ), co-occurring conditions such as anxiety or substance use, medical problems such as thyroid disease or vitamin deficiencies, and medication trials that repeated the same approach. Sometimes the depression isn’t resistant at all; it’s a different condition. Bipolar disorder often starts with depressive episodes, and hypomania can be subtle enough to miss. In a 2000 national survey of people living with bipolar disorder, 69% said they had first been misdiagnosed, most often with unipolar depression, and more than a third waited ten years or longer for an accurate diagnosis. Bipolar depression usually calls for a different medication approach, so the distinction matters. Our article on mixed features and bipolar overlap explains the signs worth raising with your psychiatrist.
A medication that didn't work is still information. It tells us which approach didn't fit, and that narrows the search.
What Depression Medication Options Come Next?
The main depression medication options after two unsuccessful trials are switching to a different medication, adding a second medication to one that partly helped, or combining two antidepressants, and the right choice depends on how you responded before. If a medication did nothing and caused side effects, switching often makes more sense. If it helped partway, adding a medication, called augmentation, can build on that gain instead of starting over. The STAR*D investigators found no differences in remission rates among the switch strategies they tested, or among the augmentation strategies, so the choice rests on your history, side effects, and preferences rather than a fixed ranking.
| Strategy | What it means | Often considered when |
|---|---|---|
| Switch | Stop one medication and start another, often one that works differently | The first medication didn’t help, or side effects outweighed benefits |
| Augment | Add a medication that isn’t an antidepressant, such as a mood stabilizer or atypical antipsychotic | The current antidepressant helped partway and was tolerated |
| Combine | Add a second antidepressant with a different mechanism | Partial response, with a clear reason to pair the two mechanisms |
| Reassess the diagnosis | Re-evaluate for bipolar disorder, anxiety, ADHD, or medical contributors | Symptoms don’t fit the expected pattern for major depression |
No row in that table is automatically better. A strategy that works well for one person can be a poor fit for another because of side effects, other medications, or health conditions. Weight gain, sexual side effects, sedation, and emotional blunting all matter, and they’re fair reasons to change course. A plan that relieves depression but leaves you feeling unlike yourself isn’t finished. For some people whose depression hasn’t responded to several medications, treatments beyond medication, such as esketamine or brain stimulation, may also be worth discussing, and a psychiatrist can explain whether a referral makes sense.
Share of participants reaching remission at each successive medication step.
Tried two antidepressants without enough relief?
A comprehensive evaluation with Dr. Farkas looks at your full history and what to try next, by telehealth across South Carolina and New York.
How Does a Psychiatrist Build a New Plan for Treatment-Resistant Depression?
A psychiatrist builds a new plan for treatment-resistant depression by re-examining the diagnosis and every earlier trial before choosing what comes next. That review is where patterns show up. Two medications that seemed different may work the same way. A trial that looked like a failure may have been stopped at week three. A recurring side effect may point toward a class to avoid. This process takes time, and it’s a partnership: you know how each medication felt, and that information shapes the plan as much as any lab result.
- Review every past trial. List each medication, the highest dose reached, how long you took it, and why it stopped.
- Confirm the diagnosis. Screen carefully for bipolar disorder, anxiety, ADHD, and other conditions that change the plan.
- Check for medical contributors. Use history and lab work to look for thyroid, vitamin, hormonal, or medication-related causes.
- Choose the next step deliberately. Match the strategy to your past responses, side-effect history, and what matters most to you.
- Measure progress. Track symptoms and side effects with standardized scales such as the PHQ-9 at each follow-up.
After these steps, expect a clear explanation of what your psychiatrist thinks is going on and why a particular strategy comes next. Expect follow-up visits every few weeks at first, because early adjustments are common. Full remission is the target, not just feeling somewhat better. STAR*D data show why that matters: at every treatment step, people who entered follow-up in remission relapsed less often than people who had only partly improved.
Side effects get the same weight as symptoms in this process. If a medication eased your depression but brought weight gain, sexual side effects, or a flattened, foggy feeling, that’s not a trade you’re expected to accept. There are often ways to adjust the dose, change the timing, or choose a different medication with a gentler side-effect profile. If you’re wondering what is treatment-resistant depression going to mean for your day-to-day care, the short answer is closer follow-up that tracks both relief and side effects.
People who entered follow-up in full remission relapsed less often than people who had only partly improved, at every step.
When Should You See a Specialist for Depression That Isn’t Improving?
It’s worth seeing a psychiatrist who focuses on complex depression if you’ve tried two or more antidepressants without enough relief, if side effects keep forcing changes, or if your diagnosis has never felt like a complete explanation. Other signs include taking several psychiatric medications without knowing why each one is there, depression that keeps returning after short improvements, and different clinicians giving you different diagnoses. None of this means you did something wrong. It means the next step deserves more time and a more detailed look. If you’re having thoughts of suicide, don’t wait for an appointment: call or text 988 in the US, or go to the nearest emergency room.
What a comprehensive evaluation looks like
A comprehensive adult psychiatric evaluation with Dr. Farkas reviews your psychiatric, medical, and family history along with every medication trial. It uses validated rating scales, looks for medical contributors, and ends with a plain-language explanation of the diagnosis and a plan you help shape. Dr. Farkas’s background as an MD/PhD psychiatrist trained in neuroscience shapes how she explains medication choices: you’ll hear why a medication is being considered and how it’s expected to work. A first evaluation typically takes 30 to 60 minutes and is available by secure telehealth for adults in South Carolina and New York.
Repeated trials, limited relief
Two or more antidepressants haven’t brought enough relief, and each new prescription starts to feel like another guess.
MD/PhD-level re-evaluation
A full re-evaluation that confirms the diagnosis, checks for medical contributors, reviews every past trial, and chooses the next step deliberately.
A plan built for remission
A plan built with you and tracked with standardized scales, aiming for full remission and a quality of life that feels like your own.

Dr. Gabriella Farkas, MD PhD
Board-certified adult psychiatrist with a PhD in neuroscience. Dr. Farkas reviews every past medication trial, dose, and side effect before recommending a next step, and explains why each option is on the table.
About Dr. Farkas →What Are Common Mistakes With Treatment-Resistant Depression?
The most common mistakes with treatment-resistant depression are judging a medication too early, stopping it abruptly, repeating the same approach without a clear reason, and assuming depression is the whole story. Stopping an antidepressant suddenly can cause discontinuation symptoms that are easy to mistake for a relapse. Physical health gets overlooked too. The National Institute of Mental Health notes that some medications and medical conditions, such as thyroid disorders, can cause symptoms that look like depression, so a plan that ignores physical health can stall.
How to avoid them
Keep a simple record of every medication, dose, start date, stop date, and the reason you stopped, and bring it to your appointment. Don’t change or stop a medication on your own; talk it through first. Tell your psychiatrist which side effects bother you most, even if they feel awkward to mention. If you’re unsure whether it’s time for a fresh look, our guide to warning signs that call for a psychiatric evaluation walks through what to watch for.
Key Terms
- Treatment-resistant depression
- Major depression that has not improved enough after at least two adequate antidepressant trials.
- Remission
- A return to minimal or no depressive symptoms, usually defined by a low score on a standardized rating scale.
- Response
- A reduction of at least 50% in depression severity on a standardized rating scale, even if some symptoms remain.
- Augmentation
- Adding a medication that is not itself an antidepressant, such as a mood stabilizer or atypical antipsychotic, to an antidepressant that has partly helped.
Common Questions About Treatment-Resistant Depression
How many antidepressants do you have to try before depression is considered treatment-resistant?
Most psychiatrists consider depression treatment-resistant after at least two antidepressants, each taken at an adequate dose for an adequate length of time, haven't brought enough improvement. This is the most common definition in research. It isn't universal, and experts still debate exact doses and durations. The quality of each trial matters more than the count. A careful history shows whether earlier trials were truly adequate.
Is treatment-resistant depression the same as untreatable depression?
No, treatment-resistant depression is not the same as untreatable depression; it means the treatments tried so far haven't worked well enough, and other options remain. Next steps can include switching medications, adding a medication, or combining approaches. Re-examining the diagnosis sometimes changes the plan entirely. Some people also benefit from treatments beyond medication. The label describes where treatment stands today, not where it has to end.
How long should I stay on an antidepressant before deciding it isn't working?
Most antidepressants need several weeks at a therapeutic dose before you can judge whether they're working, and deciding too early is a common reason trials look like failures. Some people notice changes sooner. Others need more time or a dose adjustment first. Experts don't fully agree on the exact length of an adequate trial. Your psychiatrist can help you decide when it's time to reassess.
Can bipolar disorder be mistaken for treatment-resistant depression?
Yes, bipolar disorder can be mistaken for treatment-resistant depression, because it often begins with depressive episodes and the higher-energy periods can be subtle or easy to miss. In one national survey, 69% of people with bipolar disorder reported an initial misdiagnosis. Unipolar depression was the most common misdiagnosis. Getting this right changes medication choices. Mention any stretches of high energy or little need for sleep.
Can medical problems make depression harder to treat?
Yes, medical conditions such as thyroid disorders can cause or worsen depressive symptoms, and some medications can too, which is why a thorough evaluation looks beyond mood. Sleep problems, chronic pain, and hormonal changes can also play a role. So can alcohol and other substances. Lab work and a full medical history help rule these in or out. Treating a contributing condition can make depression treatment work better.
Should I stop my antidepressant if it isn't working?
Don't stop an antidepressant on your own, even if it isn't helping, because stopping suddenly can cause discontinuation symptoms and makes it harder to judge what's happening. Talk with your prescriber first. Many medications need a gradual taper. Your psychiatrist can plan the change and the next medication together. That keeps you safer and gives the next trial a fair start.
Can I get an evaluation for treatment-resistant depression through telehealth?
Yes, Dr. Farkas offers comprehensive psychiatric evaluations by secure telehealth for adults in South Carolina and New York, with the same thoroughness as an in-person visit. You'll need a private space and a device with a camera. Plan to share your full medication history. Dr. Farkas is in-network with Aetna and Cigna. Superbills are available for other plans' out-of-network benefits.
Depression that hasn’t responded yet can still improve.
A fresh, thorough look at your history is the next step.
Sources
- Gaynes BN, Lux L, Gartlehner G, et al. “Defining treatment-resistant depression.” Depression and Anxiety, 2020;37(2):134–145. https://pubmed.ncbi.nlm.nih.gov/31638723/
- Rush AJ, Trivedi MH, Wisniewski SR, et al. “Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.” American Journal of Psychiatry, 2006;163(11):1905–1917. https://pubmed.ncbi.nlm.nih.gov/17074942/
- National Institute of Mental Health. “Depression.” NIMH Health Topics. https://www.nimh.nih.gov/health/topics/depression
- Rush AJ, Warden D, Wisniewski SR, et al. “STAR*D: revising conventional wisdom.” 2009. https://pubmed.ncbi.nlm.nih.gov/19594193/
- Warden D, Rush AJ, Trivedi MH, et al. “The STAR*D Project results: a comprehensive review of findings.” Current Psychiatry Reports, 2007;9(6):449–459. https://pubmed.ncbi.nlm.nih.gov/18221624/
- Hirschfeld RMA, Lewis L, Vornik LA. “Perceptions and impact of bipolar disorder: how far have we really come?” Journal of Clinical Psychiatry, 2003;64(2):161–174. https://www.psychiatrist.com/jcp/perceptions-impact-bipolar-disorder-far-really-results/
Educational content only. This article does not constitute medical advice and does not establish a doctor-patient relationship. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911. Treatment decisions should be made with a qualified clinician familiar with your circumstances. Last reviewed: August 2026.


